Antimicrobial resistance is projected as next pandemic with a propensity of around 10 million deaths per year by 2050. Alternatives of the antibiotic compounds are required to be explored on priority basis to treat viral, bacterial, and fungal infections. Antimicrobial peptides (AMPs) are emerging as a promising therapeutic alternative to combat serious microbial infections. Plenty of natural AMPs have been isolated and characterized from different sources posing a need of categorizing them in various databases. B…